Agomab Therapeutics

1. Ontunisertib readout2H 2026Ontunisertib readout, 2H 2026, material
2. AGMB-447 Ph1 topline2H 2026AGMB-447 Ph1 topline, 2H 2026, material
3. Ontunisertib Ph2b start2H 2026Ontunisertib Ph2b start, 2H 2026, notable
4. AGMB-447 Ph2 start2H 2026AGMB-447 Ph2 start, 2H 2026, routine

Bar width shows how precise the guidance is — a pin is a stated date, a wide band a six-month window. Deeper blue means more of the thesis rides on the event; it is not a view on the stock.